Insider · CIK 0001836883
Kathleen A. Rickard
officer
Files at VRNA (Verona Pharma plc). First filing Nov 26, 2024, latest Aug 5, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $3.7M sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 17Weak | Verona Pharma plc | $767k 58,336 shares | -2% | - | |
| 35Weak | Verona Pharma plc | $1.0M 114,984 shares | -4% | - | |
| 12Weak | Verona Pharma plc | $440k 49,200 shares | -2% | - | |
| 9Weak | Verona Pharma plc | $309k 34,384 shares | -1% | - | |
| 35Weak | Verona Pharma plc | $1.2M 240,000 shares | -8% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -2,432,868 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +1,131,984 | - | - | 1,131,984 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Ordinary Shares | -1,131,984 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -146,168 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -167,056 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -200,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitderivative | +618,760 | - | - | 618,760 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitderivative | -618,760 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Share Options (Right to Buy)derivative | -560,000 | - | - | 0 | Oct 8, 2025 |
| Oct 7, 2025 | VRNA Verona Pharma plc | DDisposition to issuer Share Options (Right to Buy)derivative | -100,000 | - | - | 0 | Oct 8, 2025 |
| Aug 29, 2025 | VRNA Verona Pharma plc | GGift Ordinary Shares | -189,600 | $0.00 | $0 | 2,417,872 | Sep 3, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +70,888 | $0.00 | $0 | 2,665,808 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -58,336 | $13.14 | $767k | 2,607,472 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Stock Unitsderivative10b5-1 | -50,000 | $0.00 | $0 | 200,000 | Aug 5, 2025 |
| Aug 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Stock Unitsderivative10b5-1 | -20,888 | $0.00 | $0 | 146,168 | Aug 5, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares | +86,064 | $0.00 | $0 | 2,632,536 | Jul 9, 2025 |
| Jul 8, 2025 | VRNA Verona Pharma plc | FTax withholding Ordinary Shares | -37,616 | $11.44 | $430k | 2,594,920 | Jul 9, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative | +253,120 | $0.00 | $0 | 253,120 | Jul 9, 2025 |
| Jul 7, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative | -86,064 | $0.00 | $0 | 167,056 | Jul 9, 2025 |
| May 6, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -114,984 | $8.82 | $1.0M | 2,546,472 | May 8, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -27,336 | $8.95 | $245k | 2,633,320 | May 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +50,000 | - | - | 2,683,320 | May 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -21,864 | $8.95 | $196k | 2,661,456 | May 5, 2025 |
| May 1, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative10b5-1 | -50,000 | $0.00 | $0 | 250,000 | May 5, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | MOption exercise Ordinary Shares10b5-1 | +86,064 | $0.00 | $0 | 2,695,040 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -34,384 | $8.98 | $309k | 2,660,656 | May 1, 2025 |
| Aug 7, 2024 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative10b5-1 | +300,000 | $0.00 | $0 | 300,000 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | AGrant or award Restricted Share Unitsderivative10b5-1 | +253,120 | $0.00 | $0 | 253,120 | May 1, 2025 |
| Apr 29, 2025 | VRNA Verona Pharma plc | MOption exercise Restricted Share Unitsderivative10b5-1 | -86,064 | $0.00 | $0 | 167,056 | May 1, 2025 |
| Nov 25, 2024 | VRNA Verona Pharma plc | SOpen-market sale Ordinary Shares10b5-1 | -240,000 | $4.90 | $1.2M | 2,671,480 | Nov 26, 2024 |
| Oct 30, 2024 | VRNA Verona Pharma plc | AGrant or award Ordinary Shares10b5-1 | +300,000 | $0.00 | $0 | 2,927,416 | Nov 1, 2024 |
| Nov 1, 2024 | VRNA Verona Pharma plc | AGrant or award Ordinary Shares10b5-1 | +50,000 | $0.00 | $0 | 2,977,416 | Nov 1, 2024 |
| Nov 1, 2024 | VRNA Verona Pharma plc | FTax withholding Ordinary Shares10b5-1 | -65,936 | $4.24 | $280k | 2,911,480 | Nov 1, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.